Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Personalized Obesity Management - Matching Dietary Fibers and Microbial Enterotype

NCT05260762
unknownnot_applicable

Effects of Inulin and Arabinoxylan on Satiety, Energy/Food Intake and Changes in the Human Gut Microbiota

NCT02846454
completednot_applicable

SATIN: Satiety Innovation. Study 2- University of Aberdeen

NCT02604316
completednot_applicable

Effect of Arabinoxylan and Rye Kernels on Second Meal Responses

NCT01583270

Clinical Trials (4)

Showing 4 of 4 trials
NCT05260762Not Applicable

Personalized Obesity Management - Matching Dietary Fibers and Microbial Enterotype

Completed
NCT02846454Not Applicable

Effects of Inulin and Arabinoxylan on Satiety, Energy/Food Intake and Changes in the Human Gut Microbiota

Unknown
NCT02604316Not Applicable

SATIN: Satiety Innovation. Study 2- University of Aberdeen

Completed
NCT01583270Not Applicable

Effect of Arabinoxylan and Rye Kernels on Second Meal Responses

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4